Global X CleanTech vs Sanofi SA — how do they compare? Global X CleanTech trades at $58.44, while Sanofi SA trades at $43.7 (market cap $104.30B). The key difference: Sanofi SA pays a 5.55% dividend while Global X CleanTech pays none, and Global X CleanTech is trading nearer its 52-week high, Sanofi SA nearer its low. Which is the better fit depends on your goals.
| CTEC | SNY | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $78.11 | $52.34 |
52-Week Low | $41.08 | $41.33 |
Market Cap | — | $104.30B |
Enterprise Value | — | $124.19B |
Dividend Yield | — | 5.55% |
Trailing returns across standard periods
Latest headlines on both assets
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →